Explicyte
  • About us
    • About us
    • The way we work
    • Management team
    • Collaborations & key partners
    • Jobs
  • Cell-based assays
    • Immune cell activation
    • Mixed lymphocyte reaction
    • Immune cell-mediated tumor killing
      • T cell killing
      • ADCC
      • Treg polarization assay
      • Th1 polarization assay
      • Th17 polarization assay
    • M2 macrophage suppression assay
    • Cell migration & chemotaxis
      • PD1/PD-L1 blockade
      • CTLA-4 blockade
  • In vivo models
    • In Vivo Models For Immuno-Oncology
      • In vivo models of CTLA-4 blockade
      • In Vivo Models of PD-1/PD-L1 axis blockade
      • In Vivo immunization tumor models
      • In vivo orthotopic glioblastoma model
      • In vivo orthotopic breast tumor model
    • Immune Cell Response Profiling
  • Capacities
    • Live cell imaging
    • Bioluminescence imaging
    • Flow cytometry
    • Microdialysis
    • Histology / Digital pathology
    • Digital Spatial Profiling
      • Cancer Transcriptome Atlas (CTA)
      • Whole Transcriptome Atlas (WTA)
    • Proteomics analysis
      • Olink - Inflammation
      • Olink - Immuno-Oncology
  • News
    • News
  • Contact us

Search in Website

Site map

Plan du site

Menu

  • About us
    • About us
    • The way we work
    • Management team
    • Collaborations & key partners
    • Jobs
  • Cell-based assays
    • Immune cell activation
    • Mixed lymphocyte reaction
    • Immune cell-mediated tumor killing
      • T cell killing
      • ADCC
      • Treg polarization assay
      • Th1 polarization assay
      • Th17 polarization assay
    • M2 macrophage suppression assay
    • Cell migration & chemotaxis
      • PD1/PD-L1 blockade
      • CTLA-4 blockade
  • In vivo models
    • In Vivo Models For Immuno-Oncology
      • In vivo models of CTLA-4 blockade
      • In Vivo Models of PD-1/PD-L1 axis blockade
      • In Vivo immunization tumor models
      • In vivo orthotopic glioblastoma model
      • In vivo orthotopic breast tumor model
    • Immune Cell Response Profiling
  • Capacities
    • Live cell imaging
    • Bioluminescence imaging
    • Flow cytometry
    • Microdialysis
    • Histology / Digital pathology
    • Digital Spatial Profiling
      • Cancer Transcriptome Atlas (CTA)
      • Whole Transcriptome Atlas (WTA)
    • Proteomics analysis
      • Olink - Inflammation
      • Olink - Immuno-Oncology
  • News
    • News
  • Contact us

Menu

  • Site map
  • Terms Of Service
  • Cookies management
  • Privacy Policy

News

  • Latest news
  • Press release & events (32)
  • Scientific communications (68)
  • Publications & Articles (18)

Contact us

I hereby accept the use of my personal data for further commercial purposes.
Collected data are used according to our Privacy Policy rules (in particular GDPR / articles 15 to 22). You can have access to your personal data and perform any request writing at explicyte at contact@explicyte.com.
 

Explicyte

  • Address: 229 Cours de l'Argonne, 33000 Bordeaux FRANCE

  • Phone: +33 (0) 5 64 31 11 70

  • Email: contact@explicyte.com

Newsletter

SUBSCRIBE OUR MAILING LIST.


Menu

  • About us
  • Cell-based assays
  • In vivo models
  • Capacities
  • News
  • Contact us

Search

Follow Explicyte

Explicyte

Copyright Explicyte Immuno-Oncology - ImmuSmol 2023 | All Rights Reserved.

Crédit d'impôt recherche
  • Site map
  • Terms Of Service
  • Cookies management
  • Privacy Policy